News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Approvals
Bay Area's Sonoma Pharma (OCLS) Wins FDA Clearance for Loyon Skin Descaler 3/29/2017
NuVasive (NUVA) Wins First-Ever FDA Clearance for Cervical Interbody Implant System Used in More Than Two Levels 3/29/2017
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis 3/29/2017
Providence Medical Technology Snags New FDA Clearances for Standalone Use of CAVUX Cervical Cage-L System and ALLY Facet Screws 3/29/2017
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor 3/28/2017
Sanofi (SNY) And Regeneron (REGN) Announce FDA Approval Of Dupixent (Dupilumab), The First Targeted Biologic Therapy For Adults With Moderate-To-Severe Atopic Dermatitis 3/28/2017
AstraZeneca PLC (AZN)'s Tagrisso Approved In China Following Priority Review 3/28/2017
Novo Nordisk Canada Inc. (NVO) Release: New Fast-Acting Mealtime Insulin, Fiasp, Now Approved And Available In Canada For The Treatment Of Diabetes 3/27/2017
iCAD (ICAD) Wins FDA Approval for PowerLook Tomo Detection 3/27/2017
FDA Green Lights Bovie Medical (BVX)'s Cool-Coag Generator and Open Handpiece 3/27/2017
EMD Serono Release: FDA Grants Approval For BAVENCIO (Avelumab), The First Immunotherapy Approved For Metastatic Merkel Cell Carcinoma 3/24/2017
Shionogi Release: FDA Approves Symproic (Naldemedine) Once-Daily Tablets C-II For The Treatment Of Opioid-Induced Constipation In Adults With Chronic Non-Cancer Pain 3/24/2017
Amgen (AMGN) Release: European Commission (EC) Approves Amgevita (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases 3/24/2017
Why Newron Pharma (NWRN)'s Newly Approved Parkinson's Drug Isn't All That Novel 3/23/2017
Medicure (MCU) Announces FDA Approval For Apicore LLC's Generic Tetrabenazine 3/23/2017
FDA Green Lights Medtronic (MDT)'s CoreValve Evolut Pro Transcatheter Valve With Advanced Sealing 3/22/2017
BioStable Science & Engineering Wins FDA Nod for Its HAART 300 Aortic Annuloplasty Device 3/22/2017
Newron Pharma (NWRN) Release: FDA Approves Xadago (Safinamide) For Parkinson's Disease (PD) Patients 3/22/2017
NovoCure Receives MHLW Approval For Second Generation Optune In Japan 3/20/2017
Surefire Receives Regulatory Approval For Infusion Systems And Guiding Catheters In Mexico 3/20/2017
Allergan (AGN) Release: JUVÉDERM VOLLURE XC Approved By U.S. FDA For Correction Of Facial Wrinkles And Folds In Adults Over The Age Of 21 3/20/2017
Toshiba Medical Systems’ New Premium Cardiovascular Ultrasound Wins FDA Approval 3/17/2017
Pfizer (PFE) Announces Approval By The China Food And Drug Administration Of XELJANZ, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis 3/16/2017
Shire (SHPG) Receives European Approval For Label Extension Of CINRYZE (C1 Inhibitor [Human]) To Prevent And Treat Hereditary Angioedema (HAE) Attacks In Paediatric Patients With HAE 3/16/2017
DJO Global (DJO) Grabs FDA Nod for Exprt Revision Hip 3/15/2017
Pfizer (PFE) Looks Over Its Shoulder as Novartis AG (NVS) Grabs a Quick Approval for Breast Cancer Drug 3/14/2017
Cambridge-based Astex Pharma (ASTX) Celebrates As Cancer Drug Receives US Marketing Approval 3/14/2017
FDA Clears Teleflex Inc. (TFX)'s Spectre Guidewire 3/14/2017
Teleflex Inc. (TFX) Wins FDA Approval of Its Twin-Pass Torque Dual Access Catheter 3/14/2017
Medtronic (MDT) Snags FDA Approval for First of Its Kind Melody Transcatheter Pulmonary Valve 3/14/2017
FDA OKs Medtronic (MDT)'s New Kyphon Xpede Bone Cement 3/14/2017
BioQ Receives Australian Regulatory Approval For Ropivacaine ReadyFusOR 3/14/2017
Ipsen (IPN.PA) Announces Health Canada Approval Of DYSPORT THERAPEUTIC (Abobotulinumtoxina) For The Treatment Of Patients With Cervical Dystonia And Adult Upper Limb Spasticity 3/14/2017
Ipsen (IPN.PA) Announces MHRA1 Approval Of New Indication For Decapeptyl For The Treatment Of Pre-Menopausal Women With Early Stage Breast Cancer 3/13/2017
Medtronic (MDT) Nabs FDA Nod for Reveal LINQ Insertable Cardiac Monitor With TruRhythm Detection 3/13/2017
PQ Bypass Wins CE Mark for DETOUR Percutaneous Bypass Technologies 3/13/2017
FDA OKs Expanded Approval of Spineology Inc.'s Elite Expandable Interbody Fusion System 3/13/2017
Clinigen Release: First-In-Class Fycompa (Perampanel) Approved In South Africa For Partial-Onset Seizures 3/10/2017
Osprey Med Nabs FDA Nod for DyeVert 3/9/2017
Teligent Announces FDA Approval Of Clobetasol Propionate Gel, 0.05% 3/8/2017
FDA Approves Serenity’s Noctiva (Desmopressin Acetate) – The First Drug Approved For The Treatment Of Nocturia 3/7/2017
Swedish Orphan AB - FDA Approves In-Use Storage At Room Temperature For Orfadin Capsules 3/7/2017
Nephros (NEP) Snags FDA Clearance of EndoPur Endotoxin 10" Filter 3/6/2017
BioCad: The First Ever Biosimilar Of Interferon Beta-1a Approved In Russia 3/6/2017
Tryton Medical Wins FDA Nod for Tryton Side Branch Stent to Treat Significant Coronary Bifurcation Lesions 3/6/2017
Teligent Announces FDA Approval Of Triamcinolone Acetonide Ointment USP, 0.5% 3/6/2017
Sobi Release: FDA Approves Increased Shelf Life And In-Use Storage At Room Temperature For Orfadin (nitisinone) 3/6/2017
Serenity Release: FDA Approves First Treatment For Frequent Urination At Night Due To Overproduction Of Urine 3/3/2017
Amend Surgical Wins FDA Nod for NanoFUSE BA 3/2/2017
Sobi Receives Approval From The EMA For Higher Capacity Drug Substance Manufacturing For Elocta 3/2/2017
FDA Approves Neocis' First Robotic System for Dental Implant Procedures 3/2/2017
Akorn, Inc. (AKN) Receives FDA Approval For Ephedrine Sulfate Injection, USP 3/2/2017
FDA Says Yes to Lexicon Pharma (LXRX)'s Carcinoid Syndrome Diarrhea Drug, Stock Soars 3/1/2017
Perrigo (PRGO) Announces FDA Final Approval For The Generic Version Of Axiron Topical Solution, 30 mg/1.5 mL 3/1/2017
FDA Green Lights CeloNova Biosciences' COBRA PzF Stent System 3/1/2017
Akorn, Inc. (AKN) Receives Approval For Mycophenolate Mofetil For Injection, USP 3/1/2017
AstraZeneca PLC (AZN) Release: FDA Approves Once-Daily QTERN (Dapagliflozin And Saxagliptin) Tablets For Adults With Type-2 Diabetes 2/28/2017
Scopis GmbH Wins FDA Clearance for Cutting-Edge ENT Surgery Navigation System 2/28/2017
Chugai Pharma's ALK Inhibitor "Alecensa" Approved In Taiwan 2/27/2017
BTG plc (BTG.L) Snags FDA Clearance for Blood Clot Device EKOS Control Unit 4.0 2/27/2017
Bracco Diagnostics Receives U.S. FDA Approval For VARIBAR PUDDING (Barium Sulfate) Oral Paste For Fluoroscopy 2/27/2017
OWC Pharmaceutical Research Corp. Receives IRB Approval To Initiate Safety Testing On Its Cannabinoid-Infused Cream For Treatment Of Psoriasis 2/27/2017
FDA Green Lights Cagent Vascular's Next Generation Vessel Dilatation Device 2/27/2017
Bay Area's Intersect ENT Grabs FDA Approval of Newest Steroid Releasing Implant, PROPEL Contour 2/24/2017
Celgene (CELG) Release: REVLIMID (Lenalidomide) Approved By European Commission (EC) As Monotherapy For The Maintenance Treatment Of Patients With Newly Diagnosed Multiple Myeloma After Autologous Stem Cell Transplantation 2/24/2017
IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Glucophage XR 2/24/2017
Celgene (CELG) Release: FDA Expands Indication For REVLIMID (Lenalidomide) As A Maintenance Treatment For Patients With Multiple Myeloma Following Autologous Hematopoietic Stem Cell Transplant (auto-HSCT) 2/23/2017
Amgen (AMGN) Wins European Commission (EC) Approval for Repatha Single-Dose Delivery Option 2/23/2017
Recovery Force Grabs FDA Nod for Active Compressions Product 2/23/2017
Celltrion Healthcare (068270.KQ) Release: Truxima, The First Biosimilar Mab In Oncology, Granted EU Marketing Authorization 2/22/2017
Chugai Pharma’s ALK Inhibitor "Alecensa" Approved In The EU 2/21/2017
Royal Philips Electronics N.V. (PHG) Snags FDA Approval for Inpatient Continuous Monitoring System 2/21/2017
Health Canada Approves Otsuka Pharma And Lundbeck (LUN.CO)'s REXULTI (Brexpiprazole) As A Treatment For Schizophrenia In Adults 2/20/2017
Voxello Snags FDA Nod for Noddle Speech Generation Device 2/20/2017
FDA Clears Expanded Indication for Medtronic (MDT)'s Freezor Xtra Cryoablation Catheter 2/17/2017
Perrigo (PRGO) Announces FDA Final Apffproval For Hydrocodone Bitartrate And Homatropine Methylbromide Oral Solution 2/17/2017
Boehringer Ingelheim Release: FDA Expands Approval Of SPIRIVA RESPIMAT (Tiotropium Bromide) Inhalation Spray For Maintenance Treatment Of Asthma In Children 2/16/2017
Boehringer Ingelheim Release: FDA Expands Approval Of Tiotropium Respimat For Maintenance Treatment Of Asthma In Children 2/16/2017
Zoetis (ZTS) Receives European Commission (EC) Approval For Stronghold Plus 2/16/2017
FDA Clears Valeant (VRX)'s New Psoriasis Drug, But With Strings Attached 2/16/2017
FlowAid Medical Tech Snags FDA Clearance for the FA100 SCCD 2/15/2017
The FDA Has Approved Tirosint-SOL, Levothyroxine In Liquid Solution For The American Market, IBSA Patent 2/15/2017
Eli Lilly (LLY) Release: European Commission (EC) Approves Once-Daily Olumiant Tablets For Treatment Of Adults With Moderate-To-Severe Active Rheumatoid Arthritis 2/14/2017
Sarepta (SRPT) Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD 2/13/2017
BIOLASE Inc. (BIOL) Wins FDA Clearance of New Waterlase Express All-Tissue Laser System 2/10/2017
FDA Greenlights ReMAP’s 7D Image Guidance System for Spine Surgeries 2/10/2017
FDA Approves Amgen (AMGN)'s Parsabiv (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis 2/8/2017
FDA Approves Bio Products Laboratory's Gammaplex 10% For Treatment Of Primary Immunodeficiency And Chronic Immune Thrombocytopenic Purpura 2/7/2017
Innovus Pharma Announces The Approval To Commercialize Zestra In South Korea Through Its Partner J&H Co. LTD 2/3/2017
Bristol-Myers Squibb (BMY) Receives FDA Approval For Opdivo (Nivolumab) In Previously Treated Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer 2/3/2017
Sobi Obtains Approval From The European Commission (EC) For New Dosing Frequency Of Orfadin 2/2/2017
FDA OKs Abbott (ABT)'s Whole-Blood Molecular Zika Test 2/2/2017
Regeneron (REGN) And Sanofi (SNY) Announce First Approval Of Kevzara (Sarilumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis In Adult Patients By Health Canada 2/1/2017
FDA Grants New Clearance for NICO Corporation's Brain Surgery Technology 2/1/2017
Merck & Co. (MRK) Release: European Commission (EC) Approves KEYTRUDA (Pembrolizumab) For First-Line Treatment Of Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression With No EGFR Or ALK Positive Tumor Mutations 2/1/2017
Sanofi (SNY)'s Xyzal Allergy 24HR Approved For Over-The-Counter Use In The United States 2/1/2017
Endo International (ENDP) Announces U.S. FDA Approval Of Ephedrine Sulfate Injection, USP 1/31/2017
FDA Approves Allergan (AGN)'s sNDA For AVYCAZ (Ceftazidime And Avibactam) To Include New Phase III Data In Patients With Complicated Urinary Tract Infections (cUTI), Including Pyelonephritis 1/30/2017
W. L. Gore & Associates Snags FDA Nod for First Balloon Expandable Stent Graft for Use in the Iliac Artery 1/30/2017
Teva (TEVA) Announces FDA Approval Of Two New RespiClick Maintenance Inhalers For The Treatment Of Asthma 1/30/2017
AstraZeneca PLC (AZN) Release: FDA Approves Symbicort For The Treatment Of Asthma In Pediatric Patients 1/30/2017
Sunovion’s Latuda (lurasidone HCl) Receives FDA Approval To Treat Adolescents With Schizophrenia 1/30/2017
Recordati Announces Marketing Approval For Cystadrops 1/27/2017
Gramercy Extremity Orthopedics Nabs a FDA Win for GEO Bone Screw System 1/26/2017
Boehringer Ingelheim Release: Jardiance (Empagliflozin) Becomes First Type 2 Diabetes Medicine In The EU To Include Cardiovascular Death Reduction Data In Label 1/26/2017
Allergan (AGN) Release: FDA Approves 72 Mcg Dose Of LINZESS (Linaclotide) For Adults With Chronic Idiopathic Constipation 1/26/2017
Globavir Biosciences, Inc. Release: Company’s Panglob Test Receives Approval For Sales And Distribution In India 1/25/2017
Adapt Pharma Release: NARCAN (Naloxone Hcl) Nasal Spray 2mg Approved By FDA 1/25/2017
Neural Analytics Release: Receives CE Mark For The Lucid System, A Next Generation, Portable Brain Monitoring Device 1/25/2017
Implanet Release: Medtech Announces Global Marketing Clearance of the New JAZZ FRAME 1/25/2017
Carmat (ALCAR.PA) Release: Company Awarded U.S. Regulatory Clearance For CANTAB Mobile 1/25/2017
Celgene (CELG) Release: Health Canada Approves REVLIMID Plus Dexamethasone As A First-Line Treatment For Patients Newly Diagnosed With Multiple Myeloma, Not Eligible For Transplant 1/24/2017
Bay Area's Prescient Surgical Wins FDA Approval for De Novo Clearance for CleanCision System 1/24/2017
Perrigo (PRGO) Release: Company Announces FDA Approval Of Its First-To-File Ab Rated Generic Version Of Topicort Spray, 0.25% 1/24/2017
FUJIFILM Release: FDA Approves The Company's Digital Breast Tomosynthesis Option For ASPIRE Cristalle Digital Mammography System 1/24/2017
BIOLASE Inc. (BIOL) Snags FDA Nod and Worldwide Launch of Its New Epic Pro Diode Laser System 1/23/2017
Synergy Pharma (SGYP) Release: TRULANCE (Plecanatide) Receives U.S. FDA Approval For The Treatment Of Adults With Chronic Idiopathic Constipation 1/20/2017
Allergan (AGN) Release: Pharma Announces FDA Approval Of Rhofade (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults 1/19/2017
Janssen Biotech (JNJ) Release: IMBRUVICA (Ibrutinib) Approved By FDA For Marginal Zone Lymphoma (MZL) Patients Who Require Systemic Therapy And Have Received At Least One Prior Anti-CD20-Based Therapy 1/19/2017
AbbVie (ABBV) Release: U.S. FDA Approves Imbruvica (Ibrutinib) As First Treatment Specifically Indicated For Relapsed/Refractory Marginal Zone Lymphoma (Mzl) - A Rare Type Of Non-Hodgkin's Lymphoma 1/19/2017
Edwards Lifesciences (EW) Nabs CE Mark for Hemosphere Blood Flow Monitor 1/19/2017
Advanced Cooling Therapy Release: Breakthrough Start-Up Advanced Cooling Therapy Receives CE Mark Approval for Use With New Control Unit 1/19/2017
SoCal's Modulated Imaging Wins FDA Nod for Ox-Imager CS System 1/19/2017
Apricus Biosciences (APRI) Release: Biotech Announces Approval Of Vitaros For The Treatment Of Erectile Dysfunction In Mexico 1/18/2017
Zealand Pharma  (ZEAL.CO) Release: EU Approval Of Suliqua Triggers $10 Million Milestone Payment To Company 1/18/2017
Teva (TEVA) Release: Company Receives FDA Approval For VANTRELATM ER (Hydrocodone Bitartrate) Extended-Release Tablets [CII] Formulated With Proprietary Abuse Deterrence Technology 1/18/2017
WuXi AppTec Release: Novel Anti-IL-6 Antibody For Rheumatoid Arthritis From WuXi-MedImmune (AZN) Joint Venture Receives Clinical Trial Permit (CTP) From CFDA 1/18/2017
Precision Spine Release: Company Announces 510(k) Clearance Of The ShurFit ACIF 2C System 1/18/2017
MindChild Medical Inc. Release: Company Announces Clearance Of A 510(K) Pre-Marketing Notification With The FDA For The MERIDIAN M110 Fetal Monitoring System 1/17/2017
Intact Vascular Release: Company's Tack Endovascular System Secures CE Mark For Repair Of Dissections Following Angioplasty Below The Knee 1/17/2017
SpineGuard Release: Medical Device Receives FDA Clearance to Market Its DSG Integration Module for Making Pedicle Screws “Smart” 1/16/2017
Bay Area's Arterys Grabs Second FDA Win for Deep Learning, Image Analysis Software 1/12/2017
Egalet Release: Drug Company Receives FDA Approval For ARYMO ER (Morphine Sulfate) C-II, An Extended-Release Morphine Product Formulated With Abuse-Deterrent Properties For Treatment Of Chronic Pain 1/10/2017
Duchesnay Release: Company Is Pleased To Announce That Health Canada Has Granted Market Authorization For Mictoryl/Mictoryl Pediatric 1/10/2017
Servier Canada Release: Health Canada Approves New Heart Failure Treatment LANCORA To Reduce Mortality And Hospitalizations 1/10/2017
Orthofix International NV (OFIX) Bags FDA and CE Mark Approvals for New Bone Growth Stimulators 1/9/2017
Biocryst (BCRX) Receives Health Canada Approval For RAPIVAB® For The Treatment Of Influenza 1/9/2017
CSL Behring Release: AFSTYLA, For Haemophilia A, Receives European Commission Approval 1/9/2017
Debiopharm's Triptorelin 6-Month Formulation Receives Approval For The Treatment Of Central Precocious Puberty (CPP) In Europe 1/9/2017
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Bendamustine Hcl Powder For IV (Treanda) 1/9/2017
Alphamab/3DMed Announce China Approval For PD-L1 Antibody Trial 1/9/2017
Globus Medical (GMED) Announces CE Mark For Excelsius GPS 1/6/2017
FDA Approves Genentech (RHHBY)’s Lucentis (Ranibizumab Injection) For Myopic Choroidal Neovascularization 1/6/2017
Eli Lilly (LLY) Release: U.S. FDA Approves Supplemental New Drug Applications To Include Landmark Data In Product Labels For Synjardy (Empagliflozin/Metformin Hydrochloride), Synjardy XR (Empagliflozin/Metformin Hydrochloride Extended-Release) And Glyxambi (Empagliflozin/Linagliptin) Tablets 1/5/2017
Axonics Modulation Tech Sacral Neuromodulation System Receives Marketing Approval From Health Canada 1/5/2017
Keystone Nano Announces FDA Approval Of Investigational New Drug Application For Ceramide NanoLiposome For The Improved Treatment Of Cancer 1/5/2017
Flashback Technologies Announces U.S. FDA De Novo Clearance To Market The First Medical Device Containing Its Compensatory Reserve Index (CRI) Algorithm 1/4/2017
Lannett (LCI) Announces Approval For Lopinavir And Ritonavir Oral Solution USP, 80 Mg/20 Mg Per mL 1/4/2017
Sobi Canada Release: Health Canada Approves Orfadin Capsules For Treatment Of Hereditary Tyrosinaemia Type-1 (HT-1) 1/4/2017
Teligent Announces FDA Approval For Three Abbreviated New Drug Applications 1/3/2017
FDA Approval of Aurobindo (AUROPHARMA.BO)'s Two Drugs Sends Stock Up 1/3/2017
Ascensia Diabetes Care Receives Health Canada Approval For The App-Enabled CONTOUR NEXT ONE Blood Glucose Monitoring System 12/29/2016
NuVasive (NUVA) To Resume XLIF Procedures In Japan In First Quarter 2017 12/29/2016
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory 12/29/2016
NanoVibronix Receives Health Canada Approval to Sell WoundShield in Canada 12/28/2016
BioNet Received Thai FDA Approval of the World's Only Available Recombinant Monovalent Acellular Pertussis (aP) Vaccine 12/27/2016
Shire (SHPG) Announces FDA Approval of Adynovate [Antihemophilic Factor (Recombinant), Pegylated] For Use In Children And Surgical Settings 12/27/2016
Nephros Inc. (NEP) Receives FDA 510(k) Clearance of HydraGuard 10" UltraFilter 12/27/2016
Alcon (ACL) Receives US FDA Approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric Intraocular Lens for Cataract Patients 12/27/2016
Amphastar Pharmaceuticals, Inc. (AMPH), Armstrong Pharmaceuticals NDA Application Not Approved 12/27/2016
Eisai Company (ESALY.PK) Release: Anticancer Agent Treakisym Approved In Japan For Additional Indication As First-Line Treatment For Low-Grade B-Cell Non-Hodgkin's Lymphoma And Mantle Cell Lymphoma 12/22/2016
Celgene (CELG) Release: Oral PDE-4 Inhibitor, OTEZLA, Approved For The Treatment Of Plaque Psoriasis And Psoriatic Arthritis In Japan 12/20/2016
Perrigo (PRGO) Announces FDA Approvals For The Store Brand OTC Equivalents To Nicorette White Ice Mint Gum 12/20/2016
Clovis Oncology (CLVS) Announces FDA Accelerated Approval Of RUBRACA (Rucaparib) For The Monotherapy Treatment Of Advanced Ovarian Cancer In Women With Deleterious Germline Or Somatic BRCA Mutations... 12/20/2016
Novo Nordisk A/S (NVO) Receives FDA Approval Of Tresiba (Insulin Degludec Injection 100 U/Ml, 200 U/Ml) For Use In Children And Adolescents With Diabetes 12/19/2016
Pfizer (PFE) Receives Approval In The European Union For Nimenrix (Meningococcal Group A, C, W-135, And Y Conjugate Vaccine) In Infants Six Weeks Of Age And Older 12/19/2016
Merck & Co. (MRK) Release: KEYTRUDA (Pembrolizumab) Approved As First Anti-PD-1 Therapy In Japan For First-Line Treatment Of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express High Levels Of PD-L1 12/19/2016
Ironwood (IRWD) Announces Approval Of LINZESS (Linaclotide) In Japan For The Treatment Of Adults With IBS-C 12/19/2016
Japan’s Ministry of Health, Labour And Welfare Approves Gilead (GILD)’s Vemlidy For Patients With Chronic Hepatitis B Virus Infection 12/19/2016
Eisai Inc. (ESALF.PK) And Arena (ARNA) Announce Regulatory Approval Of BELVIQ (Lorcaserin Hcl) In Brazil 12/19/2016
St. Jude Medical (STJ) Wins FDA Clearance of EnSite Precision Cardiac Mapping System 12/15/2016
Health Canada Approves CSL Behring's AFSTYLA For The Treatment Of Hemophilia A 12/15/2016
Anacor (ANAC) Release: FDA Approves Eucrisa For Eczema 12/15/2016
Advanced Accelerator Applications Announces European Commission (EC) Approval Of SomaKit TOC 12/15/2016
FDA Green Lights Pfizer (PFE)'s Eczema Drug Eucrisa 12/15/2016
Janssen Release: Health Canada Approves STELARA For The Treatment Of Adults With Moderately To Severely Active Crohn's Disease 12/14/2016
Eli Lilly (LLY) Release: U.S. FDA Approves Synjardy XR (Empagliflozin/Metformin Hydrochloride Extended-Release) Tablets For Adults With Type 2 Diabetes 12/13/2016
Ferring Pharma Receives EU Approval For REKOVELLE (Follitropin Delta) 12/13/2016
Lumendi Wins FDA Clearance to Market DiLumen for Endolumenal Therapy 12/13/2016
Galderma Laboratories Announces FDA Approval Of Restylane Refyne And Restylane Defyne Dermal Fillers For Treatment Of "Laugh Lines" 12/12/2016
Biogen (BIIB) And AbbVie (ABBV) Receive Health Canada Approval Of Once-Monthly ZINBRYTA (Daclizumab Beta) For Multiple Sclerosis 12/9/2016
St. Jude Medical (STJ) Nabs CE Mark for Full Body MR Conditional Labeling for Proclaim SCS System Conditional Labeling 12/8/2016
Mederi Therapeutics Inc.'s Stretta Therapy For GERD Approved In China 12/8/2016
Provision Healthcare Receives FDA Clearance of the ProNova SC360 Proton Therapy System 12/8/2016
Boehringer Ingelheim Release: FDA Approves Jardiance (Empagliflozin) Tablets To Reduce The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes And Established Cardiovascular Disease 12/6/2016
Boehringer Ingelheim Release: FDA Approves Jardiance To Reduce Cardiovascular Death In Adults With Type 2 Diabetes 12/5/2016
FDA Green Lights KYOCERA Medical's Initia Total Hip System, Featuring BIOCERAM AZUL Ceramic Femoral Head 12/5/2016
GlaxoSmithKline (GSK) Release: Relvar Ellipta 100/25 mcg Gains Approval In Japan For Use In Patients With COPD 12/2/2016
Nanowear Wins FDA OK for its Transformative Remote Diagnostic Monitoring Device 12/2/2016
Helsinn Integrative Care Wins FDA Nod for Medical Device Xonrid Gel 12/1/2016
Abbott (ABT) Bags CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform 11/30/2016
Teligent Announces FDA Approval Of Clobetasol Propionate Lotion 0.05% 11/30/2016
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Armodafinil Tablets (CIV) In 50mg, 150mg And 250 Mg Strengths (Nuvigil) 11/29/2016
Ariad (ARIA) Announces FDA Full Approval And Label Update For Iclusig (Ponatinib) Based On Long-Term Efficacy And Safety Data From Phase 2 PACE Clinical Trial 11/29/2016
Sound Options Tinnitus Treatments Release: Clinically Validated Tinnitus Treatment Gets FDA Clearance 11/29/2016
Lannett (LCI) Announces Approval For Metaxalone Tablets USP, 800 Mg 11/28/2016
Corsens Medical Announces Clearance of a 510(K) Pre-Marketing Notification With The FDA for the Corsens Cardiac Monitor 11/28/2016
International Biophysics' AffloVest Wins CE Mark Approval for Use in Europe and Elsewhere 11/28/2016
Exact Imaging Snags CE Mark Nod for Its ExactVu Prostate Imaging And Biopsy Micro-Ultrasound System 11/23/2016
Novo Nordisk A/S (NVO) Receives FDA Approval For Xultophy 100/3.6 (Insulin Degludec And Liraglutide Injection) 11/22/2016



//-->